Pharming Group N V (PHAR) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pharming Group N v   (NASDAQ: PHAR)


Pharming Group N V's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pharming Group N V's ROI in the fourth quarter of 2025?
Pharming Group N v achieved a return on average invested assets (ROI) of 0.91 % in its fourth quarter of 2025, which is below Pharming Group N V's average return on investment, which stands at 2.31%.

ROI has improved compared to -4.45% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 215 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 2361.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 24.93 % 19.51 % 13.51 % 7.47 % 1.4 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 288 277 277 277 232
Return On Investment (TTM) 0.91 % -4.45 % -4.7 % -4.98 % -5.29 %
PHAR's Overall Ranking # 2361 # 0 # # #
Seq. Investment Change TTM 5.18 % 5.56 % 5.89 % 6.26 % 0.62 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 3 -12 -12 -12 -12

PHAR Company Profile >> Back to PHAR Roi Comparisons >> See Annual PHAR Return On Investment



Return On Investment PHAR's Ranking
Within: No.
Industry # 77
Sector # 216
Overall # 2361

Return On Investment Statistics
High Average Low
11.88 %
2.31 %
-5.36 %
(Dec 31 2020)   (Dec 31 2024)







Financial Statements
Pharming Group N V's IV. Quarter Investments $ 288 Millions PHAR's Balance sheet
Pharming Group N V's IV. Quarter Income $ 3 Millions Quarterly PHAR's Income Statement
PHAR's Income by Division See PHAR's Income by Division


PHAR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 288 232 227 211 356
Y / Y Investment Growth 23.72 % 2.45 % 7.59 % -40.82 % 8.13 %
Net Income in Millions 3 -12 -11 14 16
Y / Y Net Income Growth - - - -14.52 % -57.62 %
Annual Return On Investment 0.88 % -5.09 % -4.65 % 6.48 % 4.49 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 0.88 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PHAR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PHAR's Competitors
Subscribers only: Roi for Pharming Group N V's Suppliers
Subscribers only: Return On Investment for PHAR's Customers

Other Ratios
PHAR's Roa PHAR's Inventory Turnover Ratio PHAR's Growth Rates PHAR's Dividend Statistics
PHAR's Profitability Ratios PHAR's Asset Turnover Ratio PHAR's Dividend Growth
PHAR's Roe PHAR's Valuation Ratios PHAR's Financial Strength Ratios PHAR's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Conmed Corporation  2.25 %
Revvity Inc  2.11 %
National Vision Holdings Inc   1.92 %
Repligen Corp  1.68 %
Icon Plc  1.68 %
Alvotech  1.53 %
Surgery Partners Inc   1.40 %
Grifols Sa  1.36 %
Mannkind Corporation  1.26 %
Artivion Inc   1.18 %
Envista Holdings Corporation  1.04 %
Castle Biosciences Inc   1.03 %
Innovage Holding Corp   0.91 %
Pharming Group N v   0.88 %
Pacira Biosciences inc   0.58 %
Lifestance Health Group Inc   0.50 %
Bausch Health Companies Inc   0.47 %
Radnet Inc   0.43 %
Perspective Therapeutics Inc   0.28 %
Warby Parker Inc   0.21 %

Date modified: 2026-07-07T12:47:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.